nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Proctitis—Fluorouracil—head and neck cancer	0.0279	0.0279	CcSEcCtD
Goserelin—Memory loss—Fluorouracil—head and neck cancer	0.0232	0.0232	CcSEcCtD
Goserelin—Lymphoedema—Docetaxel—head and neck cancer	0.0201	0.0201	CcSEcCtD
Goserelin—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.0157	0.0157	CcSEcCtD
Goserelin—Application site reaction—Fluorouracil—head and neck cancer	0.0145	0.0145	CcSEcCtD
Goserelin—Extravasation—Vinblastine—head and neck cancer	0.0119	0.0119	CcSEcCtD
Goserelin—Rectal haemorrhage—Vinblastine—head and neck cancer	0.0115	0.0115	CcSEcCtD
Goserelin—Febrile neutropenia—Fluorouracil—head and neck cancer	0.0113	0.0113	CcSEcCtD
Goserelin—Tenderness—Hydroxyurea—head and neck cancer	0.0108	0.0108	CcSEcCtD
Goserelin—Bone pain—Vinblastine—head and neck cancer	0.0108	0.0108	CcSEcCtD
Goserelin—Amenorrhoea—Hydroxyurea—head and neck cancer	0.0108	0.0108	CcSEcCtD
Goserelin—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.0102	0.0102	CcSEcCtD
Goserelin—Ulcer—Hydroxyurea—head and neck cancer	0.01	0.01	CcSEcCtD
Goserelin—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00963	0.00963	CcSEcCtD
Goserelin—Neoplasm—Vinblastine—head and neck cancer	0.00938	0.00938	CcSEcCtD
Goserelin—Neoplasm—Hydroxyurea—head and neck cancer	0.00855	0.00855	CcSEcCtD
Goserelin—Febrile neutropenia—Docetaxel—head and neck cancer	0.00817	0.00817	CcSEcCtD
Goserelin—Deep vein thrombosis—Docetaxel—head and neck cancer	0.00808	0.00808	CcSEcCtD
Goserelin—Polyp—Docetaxel—head and neck cancer	0.00808	0.00808	CcSEcCtD
Goserelin—Tenderness—Fluorouracil—head and neck cancer	0.00781	0.00781	CcSEcCtD
Goserelin—Extravasation—Fluorouracil—head and neck cancer	0.00781	0.00781	CcSEcCtD
Goserelin—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00769	0.00769	CcSEcCtD
Goserelin—Herpes simplex—Fluorouracil—head and neck cancer	0.00739	0.00739	CcSEcCtD
Goserelin—Cyst—Docetaxel—head and neck cancer	0.00735	0.00735	CcSEcCtD
Goserelin—Ulcer—Fluorouracil—head and neck cancer	0.0072	0.0072	CcSEcCtD
Goserelin—Angina pectoris—Vinblastine—head and neck cancer	0.00634	0.00634	CcSEcCtD
Goserelin—Breast disorder—Hydroxyurea—head and neck cancer	0.00621	0.00621	CcSEcCtD
Goserelin—Sepsis—Fluorouracil—head and neck cancer	0.00591	0.00591	CcSEcCtD
Goserelin—Depression—Vinblastine—head and neck cancer	0.00579	0.00579	CcSEcCtD
Goserelin—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00572	0.00572	CcSEcCtD
Goserelin—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00571	0.00571	CcSEcCtD
Goserelin—Myocardial infarction—Vinblastine—head and neck cancer	0.00569	0.00569	CcSEcCtD
Goserelin—Extravasation—Docetaxel—head and neck cancer	0.00563	0.00563	CcSEcCtD
Goserelin—Swelling—Fluorouracil—head and neck cancer	0.0056	0.0056	CcSEcCtD
Goserelin—Amenorrhoea—Docetaxel—head and neck cancer	0.00559	0.00559	CcSEcCtD
Goserelin—Dysuria—Hydroxyurea—head and neck cancer	0.00555	0.00555	CcSEcCtD
Goserelin—Bone disorder—Docetaxel—head and neck cancer	0.00544	0.00544	CcSEcCtD
Goserelin—Weight increased—Hydroxyurea—head and neck cancer	0.0054	0.0054	CcSEcCtD
Goserelin—Drowsiness—Hydroxyurea—head and neck cancer	0.00529	0.00529	CcSEcCtD
Goserelin—Amnesia—Fluorouracil—head and neck cancer	0.00526	0.00526	CcSEcCtD
Goserelin—Haemoglobin—Vinblastine—head and neck cancer	0.00524	0.00524	CcSEcCtD
Goserelin—Haemorrhage—Vinblastine—head and neck cancer	0.00521	0.00521	CcSEcCtD
Goserelin—Pharyngitis—Vinblastine—head and neck cancer	0.00517	0.00517	CcSEcCtD
Goserelin—Bone pain—Docetaxel—head and neck cancer	0.00513	0.00513	CcSEcCtD
Goserelin—Cardiac failure—Fluorouracil—head and neck cancer	0.00507	0.00507	CcSEcCtD
Goserelin—Lethargy—Fluorouracil—head and neck cancer	0.00504	0.00504	CcSEcCtD
Goserelin—Osteoarthritis—Fluorouracil—head and neck cancer	0.00494	0.00494	CcSEcCtD
Goserelin—Pulmonary embolism—Docetaxel—head and neck cancer	0.00492	0.00492	CcSEcCtD
Goserelin—Injection site reaction—Docetaxel—head and neck cancer	0.00489	0.00489	CcSEcCtD
Goserelin—Haemoglobin—Hydroxyurea—head and neck cancer	0.00478	0.00478	CcSEcCtD
Goserelin—Haemorrhage—Hydroxyurea—head and neck cancer	0.00475	0.00475	CcSEcCtD
Goserelin—Alopecia—Vinblastine—head and neck cancer	0.0046	0.0046	CcSEcCtD
Goserelin—Dry skin—Fluorouracil—head and neck cancer	0.00453	0.00453	CcSEcCtD
Goserelin—Neoplasm—Docetaxel—head and neck cancer	0.00444	0.00444	CcSEcCtD
Goserelin—Angiopathy—Hydroxyurea—head and neck cancer	0.00431	0.00431	CcSEcCtD
Goserelin—Sepsis—Docetaxel—head and neck cancer	0.00427	0.00427	CcSEcCtD
Goserelin—Chills—Hydroxyurea—head and neck cancer	0.00426	0.00426	CcSEcCtD
Goserelin—Ill-defined disorder—Vinblastine—head and neck cancer	0.00421	0.00421	CcSEcCtD
Goserelin—Alopecia—Hydroxyurea—head and neck cancer	0.0042	0.0042	CcSEcCtD
Goserelin—Anaemia—Vinblastine—head and neck cancer	0.00419	0.00419	CcSEcCtD
Goserelin—Angina pectoris—Fluorouracil—head and neck cancer	0.00416	0.00416	CcSEcCtD
Goserelin—Erythema—Hydroxyurea—head and neck cancer	0.00414	0.00414	CcSEcCtD
Goserelin—Thrombophlebitis—Docetaxel—head and neck cancer	0.00412	0.00412	CcSEcCtD
Goserelin—Malaise—Vinblastine—head and neck cancer	0.00409	0.00409	CcSEcCtD
Goserelin—Leukopenia—Vinblastine—head and neck cancer	0.00406	0.00406	CcSEcCtD
Goserelin—Swelling—Docetaxel—head and neck cancer	0.00404	0.00404	CcSEcCtD
Goserelin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00397	0.00397	CcSEcCtD
Goserelin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00393	0.00393	CcSEcCtD
Goserelin—Convulsion—Vinblastine—head and neck cancer	0.00393	0.00393	CcSEcCtD
Goserelin—Hypertension—Vinblastine—head and neck cancer	0.00392	0.00392	CcSEcCtD
Goserelin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.0039	0.0039	CcSEcCtD
Goserelin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00384	0.00384	CcSEcCtD
Goserelin—Pneumonia—Fluorouracil—head and neck cancer	0.00383	0.00383	CcSEcCtD
Goserelin—Anaemia—Hydroxyurea—head and neck cancer	0.00382	0.00382	CcSEcCtD
Goserelin—Discomfort—Vinblastine—head and neck cancer	0.00381	0.00381	CcSEcCtD
Goserelin—Hot flush—Docetaxel—head and neck cancer	0.00381	0.00381	CcSEcCtD
Goserelin—Menopausal symptoms—Docetaxel—head and neck cancer	0.00378	0.00378	CcSEcCtD
Goserelin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00376	0.00376	CcSEcCtD
Goserelin—Renal impairment—Docetaxel—head and neck cancer	0.00375	0.00375	CcSEcCtD
Goserelin—Myocardial infarction—Fluorouracil—head and neck cancer	0.00373	0.00373	CcSEcCtD
Goserelin—Malaise—Hydroxyurea—head and neck cancer	0.00373	0.00373	CcSEcCtD
Goserelin—Urinary tract infection—Fluorouracil—head and neck cancer	0.0037	0.0037	CcSEcCtD
Goserelin—Leukopenia—Hydroxyurea—head and neck cancer	0.0037	0.0037	CcSEcCtD
Goserelin—Cardiac failure—Docetaxel—head and neck cancer	0.00366	0.00366	CcSEcCtD
Goserelin—Lethargy—Docetaxel—head and neck cancer	0.00364	0.00364	CcSEcCtD
Goserelin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00362	0.00362	CcSEcCtD
Goserelin—Epistaxis—Fluorouracil—head and neck cancer	0.00359	0.00359	CcSEcCtD
Goserelin—Convulsion—Hydroxyurea—head and neck cancer	0.00358	0.00358	CcSEcCtD
Goserelin—Sinusitis—Fluorouracil—head and neck cancer	0.00357	0.00357	CcSEcCtD
Goserelin—Anorexia—Vinblastine—head and neck cancer	0.00353	0.00353	CcSEcCtD
Goserelin—Migraine—Docetaxel—head and neck cancer	0.00351	0.00351	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0035	0.0035	CcSEcCtD
Goserelin—Discomfort—Hydroxyurea—head and neck cancer	0.00348	0.00348	CcSEcCtD
Goserelin—Haemoglobin—Fluorouracil—head and neck cancer	0.00344	0.00344	CcSEcCtD
Goserelin—Rhinitis—Fluorouracil—head and neck cancer	0.00343	0.00343	CcSEcCtD
Goserelin—Haemorrhage—Fluorouracil—head and neck cancer	0.00342	0.00342	CcSEcCtD
Goserelin—Pharyngitis—Fluorouracil—head and neck cancer	0.00339	0.00339	CcSEcCtD
Goserelin—Oedema—Hydroxyurea—head and neck cancer	0.00338	0.00338	CcSEcCtD
Goserelin—Infection—Hydroxyurea—head and neck cancer	0.00335	0.00335	CcSEcCtD
Goserelin—Paraesthesia—Vinblastine—head and neck cancer	0.00332	0.00332	CcSEcCtD
Goserelin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00331	0.00331	CcSEcCtD
Goserelin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00331	0.00331	CcSEcCtD
Goserelin—Skin disorder—Hydroxyurea—head and neck cancer	0.00328	0.00328	CcSEcCtD
Goserelin—Dry skin—Docetaxel—head and neck cancer	0.00327	0.00327	CcSEcCtD
Goserelin—Breast disorder—Docetaxel—head and neck cancer	0.00322	0.00322	CcSEcCtD
Goserelin—Anorexia—Hydroxyurea—head and neck cancer	0.00322	0.00322	CcSEcCtD
Goserelin—Decreased appetite—Vinblastine—head and neck cancer	0.00322	0.00322	CcSEcCtD
Goserelin—Constipation—Vinblastine—head and neck cancer	0.00317	0.00317	CcSEcCtD
Goserelin—Pain—Vinblastine—head and neck cancer	0.00317	0.00317	CcSEcCtD
Goserelin—Arrhythmia—Fluorouracil—head and neck cancer	0.00306	0.00306	CcSEcCtD
Goserelin—Feeling abnormal—Vinblastine—head and neck cancer	0.00305	0.00305	CcSEcCtD
Goserelin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00303	0.00303	CcSEcCtD
Goserelin—Alopecia—Fluorouracil—head and neck cancer	0.00302	0.00302	CcSEcCtD
Goserelin—Dyspnoea—Hydroxyurea—head and neck cancer	0.00301	0.00301	CcSEcCtD
Goserelin—Angina pectoris—Docetaxel—head and neck cancer	0.003	0.003	CcSEcCtD
Goserelin—Somnolence—Hydroxyurea—head and neck cancer	0.003	0.003	CcSEcCtD
Goserelin—Erythema—Fluorouracil—head and neck cancer	0.00298	0.00298	CcSEcCtD
Goserelin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00297	0.00297	CcSEcCtD
Goserelin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00293	0.00293	CcSEcCtD
Goserelin—Abdominal pain—Vinblastine—head and neck cancer	0.00293	0.00293	CcSEcCtD
Goserelin—Fatigue—Hydroxyurea—head and neck cancer	0.00291	0.00291	CcSEcCtD
Goserelin—Pain—Hydroxyurea—head and neck cancer	0.00289	0.00289	CcSEcCtD
Goserelin—Constipation—Hydroxyurea—head and neck cancer	0.00289	0.00289	CcSEcCtD
Goserelin—Weight increased—Docetaxel—head and neck cancer	0.00281	0.00281	CcSEcCtD
Goserelin—Vision blurred—Fluorouracil—head and neck cancer	0.00281	0.00281	CcSEcCtD
Goserelin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00278	0.00278	CcSEcCtD
Goserelin—Pneumonia—Docetaxel—head and neck cancer	0.00277	0.00277	CcSEcCtD
Goserelin—Anaemia—Fluorouracil—head and neck cancer	0.00275	0.00275	CcSEcCtD
Goserelin—Hypersensitivity—Vinblastine—head and neck cancer	0.00273	0.00273	CcSEcCtD
Goserelin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00271	0.00271	CcSEcCtD
Goserelin—Renal failure—Docetaxel—head and neck cancer	0.0027	0.0027	CcSEcCtD
Goserelin—Myocardial infarction—Docetaxel—head and neck cancer	0.0027	0.0027	CcSEcCtD
Goserelin—Jaundice—Docetaxel—head and neck cancer	0.00268	0.00268	CcSEcCtD
Goserelin—Body temperature increased—Hydroxyurea—head and neck cancer	0.00267	0.00267	CcSEcCtD
Goserelin—Leukopenia—Fluorouracil—head and neck cancer	0.00266	0.00266	CcSEcCtD
Goserelin—Asthenia—Vinblastine—head and neck cancer	0.00266	0.00266	CcSEcCtD
Goserelin—Epistaxis—Docetaxel—head and neck cancer	0.00259	0.00259	CcSEcCtD
Goserelin—Convulsion—Fluorouracil—head and neck cancer	0.00258	0.00258	CcSEcCtD
Goserelin—Myalgia—Fluorouracil—head and neck cancer	0.00253	0.00253	CcSEcCtD
Goserelin—Chest pain—Fluorouracil—head and neck cancer	0.00253	0.00253	CcSEcCtD
Goserelin—Diarrhoea—Vinblastine—head and neck cancer	0.00253	0.00253	CcSEcCtD
Goserelin—Discomfort—Fluorouracil—head and neck cancer	0.0025	0.0025	CcSEcCtD
Goserelin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00249	0.00249	CcSEcCtD
Goserelin—Haemoglobin—Docetaxel—head and neck cancer	0.00248	0.00248	CcSEcCtD
Goserelin—Rhinitis—Docetaxel—head and neck cancer	0.00247	0.00247	CcSEcCtD
Goserelin—Hepatitis—Docetaxel—head and neck cancer	0.00247	0.00247	CcSEcCtD
Goserelin—Haemorrhage—Docetaxel—head and neck cancer	0.00247	0.00247	CcSEcCtD
Goserelin—Confusional state—Fluorouracil—head and neck cancer	0.00245	0.00245	CcSEcCtD
Goserelin—Pharyngitis—Docetaxel—head and neck cancer	0.00245	0.00245	CcSEcCtD
Goserelin—Dizziness—Vinblastine—head and neck cancer	0.00245	0.00245	CcSEcCtD
Goserelin—Urinary tract disorder—Docetaxel—head and neck cancer	0.00244	0.00244	CcSEcCtD
Goserelin—Oedema peripheral—Docetaxel—head and neck cancer	0.00243	0.00243	CcSEcCtD
Goserelin—Oedema—Fluorouracil—head and neck cancer	0.00243	0.00243	CcSEcCtD
Goserelin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00243	0.00243	CcSEcCtD
Goserelin—Asthenia—Hydroxyurea—head and neck cancer	0.00242	0.00242	CcSEcCtD
Goserelin—Urethral disorder—Docetaxel—head and neck cancer	0.00242	0.00242	CcSEcCtD
Goserelin—Infection—Fluorouracil—head and neck cancer	0.00241	0.00241	CcSEcCtD
Goserelin—Nervous system disorder—Fluorouracil—head and neck cancer	0.00238	0.00238	CcSEcCtD
Goserelin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00238	0.00238	CcSEcCtD
Goserelin—Tachycardia—Fluorouracil—head and neck cancer	0.00237	0.00237	CcSEcCtD
Goserelin—Vomiting—Vinblastine—head and neck cancer	0.00235	0.00235	CcSEcCtD
Goserelin—Headache—Vinblastine—head and neck cancer	0.00232	0.00232	CcSEcCtD
Goserelin—Anorexia—Fluorouracil—head and neck cancer	0.00232	0.00232	CcSEcCtD
Goserelin—Diarrhoea—Hydroxyurea—head and neck cancer	0.00231	0.00231	CcSEcCtD
Goserelin—Eye disorder—Docetaxel—head and neck cancer	0.00231	0.00231	CcSEcCtD
Goserelin—Cardiac disorder—Docetaxel—head and neck cancer	0.00229	0.00229	CcSEcCtD
Goserelin—Hypotension—Fluorouracil—head and neck cancer	0.00227	0.00227	CcSEcCtD
Goserelin—Angiopathy—Docetaxel—head and neck cancer	0.00224	0.00224	CcSEcCtD
Goserelin—Dizziness—Hydroxyurea—head and neck cancer	0.00223	0.00223	CcSEcCtD
Goserelin—Immune system disorder—Docetaxel—head and neck cancer	0.00223	0.00223	CcSEcCtD
Goserelin—Chills—Docetaxel—head and neck cancer	0.00221	0.00221	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00221	0.00221	CcSEcCtD
Goserelin—Arrhythmia—Docetaxel—head and neck cancer	0.00221	0.00221	CcSEcCtD
Goserelin—Nausea—Vinblastine—head and neck cancer	0.0022	0.0022	CcSEcCtD
Goserelin—Insomnia—Fluorouracil—head and neck cancer	0.0022	0.0022	CcSEcCtD
Goserelin—Paraesthesia—Fluorouracil—head and neck cancer	0.00218	0.00218	CcSEcCtD
Goserelin—Alopecia—Docetaxel—head and neck cancer	0.00218	0.00218	CcSEcCtD
Goserelin—Dyspnoea—Fluorouracil—head and neck cancer	0.00217	0.00217	CcSEcCtD
Goserelin—Mental disorder—Docetaxel—head and neck cancer	0.00216	0.00216	CcSEcCtD
Goserelin—Somnolence—Fluorouracil—head and neck cancer	0.00216	0.00216	CcSEcCtD
Goserelin—Erythema—Docetaxel—head and neck cancer	0.00215	0.00215	CcSEcCtD
Goserelin—Malnutrition—Docetaxel—head and neck cancer	0.00215	0.00215	CcSEcCtD
Goserelin—Vomiting—Hydroxyurea—head and neck cancer	0.00215	0.00215	CcSEcCtD
Goserelin—Dyspepsia—Fluorouracil—head and neck cancer	0.00214	0.00214	CcSEcCtD
Goserelin—Rash—Hydroxyurea—head and neck cancer	0.00213	0.00213	CcSEcCtD
Goserelin—Dermatitis—Hydroxyurea—head and neck cancer	0.00213	0.00213	CcSEcCtD
Goserelin—Headache—Hydroxyurea—head and neck cancer	0.00211	0.00211	CcSEcCtD
Goserelin—Decreased appetite—Fluorouracil—head and neck cancer	0.00211	0.00211	CcSEcCtD
Goserelin—Back pain—Docetaxel—head and neck cancer	0.00208	0.00208	CcSEcCtD
Goserelin—Pain—Fluorouracil—head and neck cancer	0.00208	0.00208	CcSEcCtD
Goserelin—Muscle spasms—Docetaxel—head and neck cancer	0.00207	0.00207	CcSEcCtD
Goserelin—Nausea—Hydroxyurea—head and neck cancer	0.00201	0.00201	CcSEcCtD
Goserelin—Feeling abnormal—Fluorouracil—head and neck cancer	0.002	0.002	CcSEcCtD
Goserelin—Anaemia—Docetaxel—head and neck cancer	0.00199	0.00199	CcSEcCtD
Goserelin—Urticaria—Fluorouracil—head and neck cancer	0.00193	0.00193	CcSEcCtD
Goserelin—Leukopenia—Docetaxel—head and neck cancer	0.00192	0.00192	CcSEcCtD
Goserelin—Body temperature increased—Fluorouracil—head and neck cancer	0.00192	0.00192	CcSEcCtD
Goserelin—Palpitations—Docetaxel—head and neck cancer	0.0019	0.0019	CcSEcCtD
Goserelin—Cough—Docetaxel—head and neck cancer	0.00188	0.00188	CcSEcCtD
Goserelin—Convulsion—Docetaxel—head and neck cancer	0.00186	0.00186	CcSEcCtD
Goserelin—Hypertension—Docetaxel—head and neck cancer	0.00186	0.00186	CcSEcCtD
Goserelin—Arthralgia—Docetaxel—head and neck cancer	0.00183	0.00183	CcSEcCtD
Goserelin—Chest pain—Docetaxel—head and neck cancer	0.00183	0.00183	CcSEcCtD
Goserelin—Myalgia—Docetaxel—head and neck cancer	0.00183	0.00183	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00182	0.00182	CcSEcCtD
Goserelin—Hypersensitivity—Fluorouracil—head and neck cancer	0.00179	0.00179	CcSEcCtD
Goserelin—Dry mouth—Docetaxel—head and neck cancer	0.00179	0.00179	CcSEcCtD
Goserelin—Confusional state—Docetaxel—head and neck cancer	0.00177	0.00177	CcSEcCtD
Goserelin—Anaphylactic shock—Docetaxel—head and neck cancer	0.00175	0.00175	CcSEcCtD
Goserelin—Oedema—Docetaxel—head and neck cancer	0.00175	0.00175	CcSEcCtD
Goserelin—Infection—Docetaxel—head and neck cancer	0.00174	0.00174	CcSEcCtD
Goserelin—Shock—Docetaxel—head and neck cancer	0.00173	0.00173	CcSEcCtD
Goserelin—Nervous system disorder—Docetaxel—head and neck cancer	0.00172	0.00172	CcSEcCtD
Goserelin—Pruritus—Fluorouracil—head and neck cancer	0.00172	0.00172	CcSEcCtD
Goserelin—Thrombocytopenia—Docetaxel—head and neck cancer	0.00172	0.00172	CcSEcCtD
Goserelin—Tachycardia—Docetaxel—head and neck cancer	0.00171	0.00171	CcSEcCtD
Goserelin—Skin disorder—Docetaxel—head and neck cancer	0.0017	0.0017	CcSEcCtD
Goserelin—Anorexia—Docetaxel—head and neck cancer	0.00167	0.00167	CcSEcCtD
Goserelin—Diarrhoea—Fluorouracil—head and neck cancer	0.00166	0.00166	CcSEcCtD
Goserelin—Hypotension—Docetaxel—head and neck cancer	0.00164	0.00164	CcSEcCtD
Goserelin—Dizziness—Fluorouracil—head and neck cancer	0.00161	0.00161	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.0016	0.0016	CcSEcCtD
Goserelin—Insomnia—Docetaxel—head and neck cancer	0.00159	0.00159	CcSEcCtD
Goserelin—Paraesthesia—Docetaxel—head and neck cancer	0.00157	0.00157	CcSEcCtD
Goserelin—Dyspnoea—Docetaxel—head and neck cancer	0.00156	0.00156	CcSEcCtD
Goserelin—Somnolence—Docetaxel—head and neck cancer	0.00156	0.00156	CcSEcCtD
Goserelin—Vomiting—Fluorouracil—head and neck cancer	0.00154	0.00154	CcSEcCtD
Goserelin—Dyspepsia—Docetaxel—head and neck cancer	0.00154	0.00154	CcSEcCtD
Goserelin—Rash—Fluorouracil—head and neck cancer	0.00153	0.00153	CcSEcCtD
Goserelin—Dermatitis—Fluorouracil—head and neck cancer	0.00153	0.00153	CcSEcCtD
Goserelin—Decreased appetite—Docetaxel—head and neck cancer	0.00152	0.00152	CcSEcCtD
Goserelin—Headache—Fluorouracil—head and neck cancer	0.00152	0.00152	CcSEcCtD
Goserelin—Fatigue—Docetaxel—head and neck cancer	0.00151	0.00151	CcSEcCtD
Goserelin—Pain—Docetaxel—head and neck cancer	0.0015	0.0015	CcSEcCtD
Goserelin—Constipation—Docetaxel—head and neck cancer	0.0015	0.0015	CcSEcCtD
Goserelin—Feeling abnormal—Docetaxel—head and neck cancer	0.00145	0.00145	CcSEcCtD
Goserelin—Nausea—Fluorouracil—head and neck cancer	0.00144	0.00144	CcSEcCtD
Goserelin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00143	0.00143	CcSEcCtD
Goserelin—Body temperature increased—Docetaxel—head and neck cancer	0.00139	0.00139	CcSEcCtD
Goserelin—Abdominal pain—Docetaxel—head and neck cancer	0.00139	0.00139	CcSEcCtD
Goserelin—Hypersensitivity—Docetaxel—head and neck cancer	0.00129	0.00129	CcSEcCtD
Goserelin—Asthenia—Docetaxel—head and neck cancer	0.00126	0.00126	CcSEcCtD
Goserelin—Pruritus—Docetaxel—head and neck cancer	0.00124	0.00124	CcSEcCtD
Goserelin—Diarrhoea—Docetaxel—head and neck cancer	0.0012	0.0012	CcSEcCtD
Goserelin—Dizziness—Docetaxel—head and neck cancer	0.00116	0.00116	CcSEcCtD
Goserelin—Vomiting—Docetaxel—head and neck cancer	0.00112	0.00112	CcSEcCtD
Goserelin—Rash—Docetaxel—head and neck cancer	0.00111	0.00111	CcSEcCtD
Goserelin—Dermatitis—Docetaxel—head and neck cancer	0.0011	0.0011	CcSEcCtD
Goserelin—Headache—Docetaxel—head and neck cancer	0.0011	0.0011	CcSEcCtD
Goserelin—Nausea—Docetaxel—head and neck cancer	0.00104	0.00104	CcSEcCtD
